| View |
|
DRP-6206-01
|
Carboplatin
|
None
|
10mg/mL
|
Solution for Injection (IV Infusion)
|
Antineoplastic
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
21 March 2022
|
16 July 2027
|
| View |
|
DRP-5412-07
|
Methylprednisolone
|
Predmore
|
16 mg
|
Tablet
|
Corticosteroid (Glucocorticoid)
|
HEALER'S LAB. Unit II
|
India
|
Renewal
|
11 August 2024
|
04 August 2029
|
| View |
|
DRP-5485-01
|
Etoricoxib
|
Ardixtor
|
120 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
MAGBRO HEALTHCARE PVT.LTD.
|
India
|
Renewal
|
04 August 2024
|
27 August 2029
|
| View |
|
DRP-10462
|
Cefepime (As Hydrochloride)
|
Neupime
|
1g per vial
|
Powder For Injection (IM/IV)
|
-
|
Neutro Pharma (Pvt.) Ltd.
|
Pakistan
|
-
|
30 September 2021
|
03 March 2025
|
| View |
|
DRP-2504-01
|
Glipizide
|
None
|
5 mg
|
Tablet
|
-
|
Centurion Remedies Pvt. Ltd.
|
India
|
Initial
|
29 September 2021
|
30 September 2025
|
| View |
|
DRP-4373-06
|
Amlodipine (As Besilate)
|
Neocard
|
5 mg
|
Tablet
|
-
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
-
|
28 September 2021
|
28 March 2026
|
| View |
|
DRP-3108-04
|
Amlodipine (As Besilate)
|
Neocard
|
10 mg
|
Tablet
|
-
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
-
|
28 September 2021
|
08 July 2026
|
| View |
|
DRP-8678-01
|
Clozapine
|
Unbranded
|
100 mg
|
Tablet
|
Antipsychotic
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Renewal
|
07 November 2023
|
04 October 2028
|
| View |
|
DRP-8677-01
|
Quetiapine(As Fumarate)
|
None
|
300 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Automatic Renewal
|
09 January 2023
|
12 October 2027
|
| View |
|
DRP-9244-02
|
Salbutamol (As Sulfate)
|
Salmate
|
1mg/mL (2.5mg/2.5mL)
|
Solution for Inhalation
|
-
|
Legency Remedies Pvt. Ltd.
|
India
|
-
|
29 September 2021
|
09 June 2025
|
| View |
|
DR-XY47407
|
Ascorbic Acid
|
Neo-Cee
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
-
|
Compact Pharmaceuticals, Corp.
|
Philippines
|
-
|
02 March 2022
|
24 September 2026
|
| View |
|
DRP-5390-04
|
Mefenamic Acid
|
Flamicid
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
11 July 2024
|
11 July 2029
|
| View |
|
DRP-4496-04
|
Mefenamic Acid
|
Flamicid
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
25 July 2023
|
02 July 2028
|
| View |
|
DR-XY47431
|
Ascorbic Acid + Zinc
|
Boss-Z
|
500 mg (equivalent to 568.18 mg Sodium Ascorbate)
/10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Northfield Laboratories Inc.
|
Philippines
|
-
|
29 September 2021
|
29 September 2026
|
| View |
|
DRP-10420
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
Dzn 400
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/
400 IU/20 mg (equivalent to 54.90 mg Zinc Sulfate
Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
29 September 2021
|
29 September 2026
|
| View |
|
DRP-10443
|
Folic Acid (Vitamin B9)
|
None
|
5 mg
|
Tablet
|
-
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid
Oral Dosage Facility)
|
India
|
-
|
30 September 2021
|
30 September 2026
|
| View |
|
DRP-5035-01
|
Imatinib (as mesilate)
|
Unbranded
|
100 mg
|
Capsule
|
Antineoplastic Agent
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
Renewal
|
18 October 2023
|
07 January 2029
|
| View |
|
DRP-10459
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3)
|
Enerisch D
|
500 mg (equivalent to 562.5 mg Sodium Ascorbate)/ 20
mg (equivalent to 54.90 mg Zinc Sulfate Monohydrate)
400 IU
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
28 September 2021
|
28 September 2026
|
| View |
|
DRP-10236
|
Calcium Lactate
|
Calxate
|
325mg
|
Tablet
|
Mineral
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd
|
China
|
Initial[OTC]
|
29 September 2021
|
29 September 2026
|
| View |
|
DRP-10416
|
Zinc
|
Eba Z
|
30 mg (equivalent to 208.8 mg Zinc Gluconate)
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
29 September 2021
|
29 September 2026
|